Strategic Partnerships Functional Fluidics collaborates with pharmaceutical and biotech companies across the clinical development lifecycle, creating opportunities for co-development guidance, trial support, and real-world evidence generation in sickle cell disease which can open doors for partner-led programs and services.

Rare Disease Focus The company targets sickle cell disease and transfusion medicine, addressing under-resourced areas and high-need regions such as sub-Saharan Africa, presenting a path to expand reach with diagnostics, patient access programs, and clinical operations support tailored to underserved markets.

Clinical & Real-World By generating real-world evidence and partnering with clinical and academic institutions, Functional Fluidics can offer data analytics, study design input, and translational insights that enhance sponsor trials and post-market surveillance.

Growth Signals Recent NYBC Ventures investment signals external validation and potential momentum; leverage this funding trajectory to position offerings around early-stage collaboration, proof-of-concept studies, and scalable clinical operations support for SCD therapies.

Mid-Sized Niche Play As a smaller, Detroit-based organization with healthcare tech acumen and a focused mission, there is an opportunity to upsell specialized services such as regulatory readiness, site network coordination, investigator engagement, and payer-informed trial design to niche customers seeking agile partners.